Their research findings further indicated that the interaction between IL-33 and ST2 could up-regulate the level of glucose transporter type 1 (GLUT1) in the cell membrane, thereby enhancing the glucose uptake and glycolysis of lung cancer cells, and providing optimal energy support for the malignant growth of lung cancer cells. Here, SLC2A1 is linked to lung carcinoma.